dihydroergotamine has been researched along with Coronary Vasospasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, BD; Schenkat, DH; Schulz, LT | 1 |
| Husfeldt, KJ; Kaiser, H; Majer, M; Schäfer, D; Sunder-Plassmann, L; Voigt, J; Welzel, D; Wolf, H | 1 |
2 other study(ies) available for dihydroergotamine and Coronary Vasospasm
| Article | Year |
|---|---|
Dihydroergotamine-induced vasospastic angina in a patient taking a calcium channel blocker.
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Vasospasm; Dihydroergotamine; Drug Interactions; Female; Headache; Humans; Hypertension; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Practice Guidelines as Topic; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 2011 |
[Evaluation of the prevention of perioperative thromboembolism with low molecular weight heparin and dihydroergotamine. A study of the incidence of lethal pulmonary embolisms and undesired symptoms, especially the risk of vasospasm and myocardial infarcti
Topics: Coronary Disease; Coronary Vasospasm; Dihydroergotamine; Female; Heparin; Humans; Male; Myocardial Infarction; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Risk Factors | 1988 |